Brown University ANTENATAL GENITOURINARY ANOMALIES Evaluation and - - PowerPoint PPT Presentation

brown university antenatal
SMART_READER_LITE
LIVE PREVIEW

Brown University ANTENATAL GENITOURINARY ANOMALIES Evaluation and - - PowerPoint PPT Presentation

Brown University ANTENATAL GENITOURINARY ANOMALIES Evaluation and Management Pamela Ellsworth, Anthony A. Caldamone Hasbro Childrens Hospital Brown University Fetal medicine October 2011 PRENATAL ULTRASOUND Are we discovering the


slide-1
SLIDE 1

Brown University

slide-2
SLIDE 2

ANTENATAL GENITOURINARY ANOMALIES Evaluation and Management

Pamela Ellsworth, Anthony A. Caldamone Hasbro Children’s Hospital Brown University Fetal medicine October 2011

slide-3
SLIDE 3

PRENATAL ULTRASOUND Are we discovering the obvious? Are we making a difference?

slide-4
SLIDE 4

WHAT CAN WE DETECT IN THE GENITOURINARY TRACT PRENATALLY?

 Hydronephrosis  Absence of kidney(s)  Abnormally developed

renal parenchyma

 Renal cystic disease

 Abnormal bladder

development

 Obstructed  Exstrophied  Absence

 Genital anomalies

 Inadequately developed

male genitalia

 Hydrocele

MCDK

slide-5
SLIDE 5

WHAT CAN WE DETECT IN THE GENITOURINARY TRACT PRENATALLY?

 Hydronephrosis  Absence of kidney(s)  Abnormally developed renal

parenchyma

 Renal cystic disease

 Abnormal bladder development

 Obstructed  Exstrophied  Absence

 Genital anomalies

 Inadequately developed male genitalia  Hydrocele

slide-6
SLIDE 6

WHAT CAN WE DETECT IN THE GENITOURINARY TRACT PRENATALLY?

 Hydronephrosis  Absence of kidney(s)  Abnormally developed renal

parenchyma

 Renal cystic disease

 Abnormal bladder development

 Obstructed  Exstrophied  Absence

 Genital anomalies

 Inadequately developed male

genitalia

 Hydrocele

slide-7
SLIDE 7

HYDRONEPHROSIS

 Description of appearance

  • f upper urinary tract

 Collecting system

 Calyces and pelvis  Ureter

 Is NOT a disease /

disorder = sign

 Not always indicative of

  • bstruction

 Pattern may imply etiology

UPJ

slide-8
SLIDE 8

PRIMARY MEGAURETER UVJ OBSTRUCTION

slide-9
SLIDE 9

VESICOURETERAL REFLUX

slide-10
SLIDE 10

HYDRONEPHROSIS Etiologies

Obstruction [Renal or bladder] Vesicoureteral reflux Obstruction and reflux Nonobstructive and non-refluxing (Physiologic)

slide-11
SLIDE 11

PRENATAL GU MILESTONES

Kidneys first detectable………….13 wks

Hydronephrosis…………………….16 wks

Internal renal structure distinct

Kidney surrounded by fat…………..20 wks

Fetal bladder

Filling/emptying cycles……………..15 wks

Ureters normally not visualized

slide-12
SLIDE 12

Grade 2 Grade 3 Grade 4 HYDRONEPHROSIS Definition: enlargement of renal collecting system including renal calyces, pelvis, with or without ureters SFU Classification

slide-13
SLIDE 13

PRENATAL HYDRO INCIDENCE

Most common prenatal anomaly

30 – 50% prenatal US anomalies

Urinary tract dilation:

1/100 pregnancies (1%): pelviectasis or

greater

Significant uropathy: 1/500 (0.2%)

slide-14
SLIDE 14

DEFINING PRENATAL HYDRONEPHROSIS

 AP diameter

 Simplest and most sensitive

parameter

(Corteville JE et al., Am J Obstet Gynecol, 1991)  Dependent upon gestational

age

 More significant with

calyceal / ureteral dilatation

(Harding LJ et al., Prenat Diagn, 1999; Kent A et al., Prenat Diagn, 2000)

SFU

AP

slide-15
SLIDE 15

PRENATAL GRADING OF HYDRONEPHROSIS

Grade Calyceal Dilatation Size of Pelvis (mm)

I Normal calyces <10 II Normal calyces 10-15 III Slight dilatation >15 IV Moderate dilatation >15 V Severe dilatation & >15 atrophic cortex Predictive of outcome – somewhat!

slide-16
SLIDE 16

WHAT ELSE TO LOOK FOR

Kidney: Degree of dilation Renal parenchyma echogenecity / thickness Calyceal-pelviectasis Unilateral vs bilateral Variation in hydro Ureter: Ureteral dilation Bladder: Size and emptying Urethra: Post. urethral dilation Other: Amniotic fluid volume Extra renal fluid Other anomalies Gender Overall growth and development

slide-17
SLIDE 17

Differential Diagnosis of Prenatal Hydronephrosis

Unilateral:

 UPJ obstruction (39-64%)  UVJ obstruction (9-14%)  Vesicoureteral reflux (33%)  MCDK (4-25%)  Ureterocele/ ectopic ureter  Duplex system  PCKD  Physiologic  Extra-renal pelvis

Bilateral:

 Posterior urethral valves (2-

9%)

 Vesicoureteral reflux  Urethral aplasia  Prune belly syndrome  Megacystis-megaureter  PCKD

slide-18
SLIDE 18

Unilateral:

  • UPJ obstruction (39-64%)
  • UVJ obstruction (9-14%)
  • Vesicoureteral reflux (33%)
  • MCDK (4-25%)
  • Ureterocele/ ectopic ureter / Duplex

system

  • PCKD
  • Physiologic
  • Extra-renal pelvis

Unilateral:

  • UPJ obstruction (39-64%)
  • UVJ obstruction (9-14%)
  • Vesicoureteral reflux (33%)
  • MCDK (4-25%)
  • Ureterocele/ Ectopic ureter / Duplex

system

  • PCKD
  • Physiologic
  • Extra-renal pelvis
slide-19
SLIDE 19

Unilateral:

  • UPJ obstruction (39-64%)
  • UVJ obstruction (9-14%)
  • Vesicoureteral reflux (33%)
  • MCDK (4-25%)
  • Ureterocele/ ectopic ureter / Duplex

system

  • PCKD
  • Physiologic
  • Extra-renal pelvis
slide-20
SLIDE 20

Unilateral:

  • UPJ obstruction (39-64%)
  • UVJ obstruction (9-14%)
  • Vesicoureteral reflux (33%)
  • MCDK (4-25%)
  • Ureterocele / ectopic ureter / duplex

system

  • PCKD
  • Physiologic
  • Extra-renal pelvis
slide-21
SLIDE 21

What is the Fate of Prenatal Hydronephrosis ?

Prenatal US Postnatal US

slide-22
SLIDE 22

Natural History of Prenatal Hydronephrosis

(Sairam et al., Ultrasound Obstet Gynecol 2001)

11465 scan at 18-23 wks [2nd trimester]

N= 268 (2.3%)

4-7 mm (81%) > 7 mm (19%)

80% Resolved Antenatally 20% Persisted @ birth 82% Resolved @ 1 mos. 18% Persisted @ 1 mos. All resolved > 1 yr. 0% Resolved Antenatally 100% Persisted @ birth 44% Resolved @ 1 mos. 31% had surgery (>10 mm) 14% Abx. 11% Death

slide-23
SLIDE 23

ETIOLOGY OF HYDRO RESOLUTION

 Fetal urine flow

 4 - 6 X > postnatal

 Change in collecting

system and ureteral compliance

 Increased collagen

 Fetal ureteral folds

 Longer ureter than needed

early in gestation

Prenatal Postnatal

slide-24
SLIDE 24

CONSEQUENCES OF HYDRONEPHROSIS

 Urinary tract infection Pyelonephritis 10% renal scarring

Hypertension Loss of Renal Function End Stage Renal Disease

 Upper tract pressure Renal parenchymal atrophy

slide-25
SLIDE 25

IMPACT OF PRENATAL DIAGNOSIS HYDRONEPHROSIS

Reduction of postnatal UTI Preservation of renal function Prevention of acquired renal damage ? Reduction in frequency of postnatal

presentation

slide-26
SLIDE 26

IMPACT OF PRENATAL DIAGNOSIS

 Does prenatal ultrasound afford preservation of renal function?  Ureterocele/duplicated systems

 Tackett, et al AAP 1997  Bolduc J Urol 2002

 No effect on upper pole function

 PUV

 El Ghoneimi, et al J Urol 1999

 No effect - same degree renal failure (30%)

 Kousidis G et al BJUInt 2008

 Moderate improvement renal function long-term

slide-27
SLIDE 27

UPPER TRACT HYDRONEPHROSIS OUTCOME

SFU consensus statement

Prenatal hydronephrosis resolves in majority

“mild” – 12% UT pathology “severe” – 88% UT pathology < 5% require surgery

No studies concluding outcomes benefit: renal

function

Nguyen HT et al JPU 2010

slide-28
SLIDE 28

Does prenatal ultrasound change the pathology that we see?

slide-29
SLIDE 29

DOES PRENATAL US CHANGE THE PATHOLOGY?

 Prenatal VUR- multicenter study  56 males / 15 females - 116

refluxing units

 20% Grade 3-5 VUR resolved

 0.9 years boys / 2.1 years girls  Conclusion: Prenatal VUR high grade /

males/ bilateral /renal dysplasia / high resolution rate Herndon et al J Urology, 1999

slide-30
SLIDE 30

PRENATAL IMPACT ZERIN STUDY

 200 consecutive children 6 year period UPJ / MCDK Ureteroceles / megaureters  2 groups Prenatal presentation Older (symptomatic) presentation

SEMIN US CT MR 1994

slide-31
SLIDE 31

PRENATAL IMPACT ZERIN STUDY

UPJ / MCDK results Doubled incidence No change in incidence of late presentation

Prenatal ultrasound increases detection

slide-32
SLIDE 32

PRENATAL IMPACT ZERIN STUDY

Ureterocele / Megaureter No change overall number of cases over 6

year period

Ureterocele prenatal diagnosis: 17 83% Megaureter prenatal diagnosis: 50 83% Corresponding decrease of symptomatic

presentation of ureterocele and megaureters

slide-33
SLIDE 33

BENEFIT OF PRENATAL DIAGNOSIS

 Presymptomatic diagnosis

 Ureterocele / megaureter

 Increased diagnosis of abnormalities

 UPJ / MCDK

 Avoid pyelonephritis

 High incidence renal scarring in infants  High incidence of bacteremia and sepsis

 Preservation of renal function

 No evidence

MCDK

slide-34
SLIDE 34

OUTCOME PREDICTION ? Bilateral Hydronephrosis

Bladder Outlet Obstruction

slide-35
SLIDE 35

POSTERIOR URETHRAL VALVES

BLADDER POSTERIOR URETHRA PUV

Normal VCUG

30% end stage renal disease

slide-36
SLIDE 36

HYDRONEPHROSIS: FACTORS PREDICTIVE OF OUTCOME

Amniotic fluid volume Parenchymal echogenicity Degree of hydronephrosis Renal function

Urinary chemistries - sequential B-1 microglobulin

Electrolytes Isotonicity

Other anomalies

Chromosomes (8-10% abnormal)

slide-37
SLIDE 37

AMNIOTIC FLUID

Mid 2nd Tri =90% AF

slide-38
SLIDE 38

OLIGOHYDRAMNIOS

 4 - 5% pregnancies  Amniotic fluid leak  Amnion nodosum  Urinary tract anomalies  Consequences Pressure anomalies Potter’s characteristics Pulmonary hypoplasia

slide-39
SLIDE 39

AMNIOTIC FLUID

Pulmonary development

23 – 26 wk Prevents extensive compression Stenting of tubules Tubules developed by 24 weeks

Prevents compression deformities

Head Thorax Extremities

slide-40
SLIDE 40

OLIGOHYDRAMNIOS Urinary Tract Anomalies

Bilateral hydronephrosis

Bladder outlet obstruction Abnormal renal parenchymal development

(secondary)

Abnormal renal parenchymal development

(primary)

Bilateral renal dysplasia / cystic disease With or without hydronephrosis Bilateral renal agenesis / hypoplasia

slide-41
SLIDE 41

PROGNOSTIC FACTORS IN PRENATAL HYDRO

Multivariant analysis 148

children

Oligohydramnios Prematurity Initial GFR <20ml/min

Oliviera et al Ped Neph 1999

Increased perinatal demise Poor postnatal renal function

slide-42
SLIDE 42

PROGNOSTIC FACTORS IN PRENATAL HYDRO

Echogenicity Parenchymal Thinning

slide-43
SLIDE 43

PRENATAL ULTRASOUND: PREDICTIVE FACTORS

Echogenicity

Chi et al J Urol 2006

slide-44
SLIDE 44

PRENATAL ULTRASOUND: PREDICTIVE FACTORS

Renal parenchymal thinning

Chi et al J Urol 2006

slide-45
SLIDE 45

FACTORS PREDICTIVE OF OUTCOME

Amniotic fluid volume Parenchymal echogenicity Degree of hydronephrosis

Poor predictor of postnatal renal function

Renal function Other anomalies

Chromosomes (8-10% abnormal)

slide-46
SLIDE 46

FETAL URINARY BIOCHEMISTRIES

Urine production @ 13 weeks

Ultrafiltrate of fetal serum Hypotonic - selective resorption Na/Cl

Poor prognosis

Isotonic urine (“salt wasting”)

Loss of ability to resorb Na/Cl

slide-47
SLIDE 47

PROGNOSTIC CRITERIA NORMAL VALUES

Na

<100 mEq/L

Cl

<90 mEq/L

Osm

<210 mOsm/L

Ca

<2 mmol/L

PO4

<2 mmol/L

B2-microglobulin

<2 mg/L

No cortical cysts

/ Normal echogenicity

slide-48
SLIDE 48

What Work-Up is Needed in Evaluating Prenatal Hydronephrosis ?

Postnatal US VCUG IVP MRI Diuretic Renogram

slide-49
SLIDE 49

Prenatal Hydronephrosis - Majority

Unilateral with normal contralateral kidney Evaluation: Ultrasound at >7 – 10 days

Mild Moderate/Severe Serial Ultrasound VCUG Renal Scan MAG3 or IVP

slide-50
SLIDE 50

Bilateral Group

Require prompt evaluation – especially

male infant (PUV)

Ultrasound and VCUG prior to discharge

Treatment of valves, obstructive ureterocele Antibiotic prophylaxis - non-obstructive

lesions

slide-51
SLIDE 51

Differential Diagnosis

Transient / Physiologic

50-70%

UPJ obstruction

10-30%

VUR

10-40%

Primary Megaureter

5-15%

MCDK

2-5%

PUV

1-5%

Ureterocele, ectopic ureter, duplex system,

urethral atresia, Prune Belly, PCKD, renal cysts

slide-52
SLIDE 52

PRENATAL INTERVENTION FOR GENITOURINARY ANOMALIES

Pamela Ellsworth, Anthony A. Caldamone Fetal Medicine October 2011

slide-53
SLIDE 53

GENERIC PRENATAL INTERVENTION ISSUES

 Accuracy of diagnosis  Indications for intervention  Contraindications for

intervention

 Risks of intervention  Consequences of nonintervention  Ethical considerations

slide-54
SLIDE 54

PRENATALLY DETECTED HYDRONEPHROSIS INTERVENTION

 Ureteropelvic junction obstruction  Ureterovesical junction obstruction  Vesicoureteral reflux  Bladder outlet obstruction

 Posterior urethral valves Urethral atresia  Sacrococcygeal teratoma  Intestinal duplication  Ureterocele  Neuropathic bladder

 Duplicated collecting systems

 Ectopic ureter  Ureterocele

 Prune belly syndrome  Multicystic dysplastic kidney

Solitary kidney

slide-55
SLIDE 55

SIGNS OF BLADDER OUTLET OBSTRUCTION

 Bilateral hydroureteronephrosis  Persistent bladder distention Incomplete emptying  Bladder wall thickening  Perinephric urinoma  Ascites  Oligohydramnios  Dilated posterior urethra

slide-56
SLIDE 56

BLADDER OUTLET OBSTRUCTION

Differential diagnosis

Posterior urethral valves Prune Belly Syndrome Urethral atresia VUR Megacystis - Megaureter Ureterocele

slide-57
SLIDE 57

POSTERIOR URETHRAL VALVES

Bladder

slide-58
SLIDE 58

SPECTRUM OF PUV

Prenatal hydro / transplant @ 5 y.o. VUR Renal Dysplasia

slide-59
SLIDE 59

PUV CONSEQUENCES OF NONINTERVENTION

Newborn mortality: 5 – 10% Chronic renal failure: 30 – 35% Predictors of postnatal outcome

Renal parenchyma quality Serum chemistries – nadir Vesicoureteral reflux Age at diagnosis

slide-60
SLIDE 60

GOALS OF INTERVENTION

Preserve renal function Never demonstrated clinically /

experimentally

Prevent pulmonary hypoplasia Mechanical restriction lung growth /

chest expansion

Insufficient AF inhibits lung branching

slide-61
SLIDE 61

VARIABLES EFFECTING POSTNATAL RENAL FUNCTION

 Renal dysplasia

 Predetermined non-reversible at any stage of detection or

intervention

 Begins at 5 – 8 weeks

 Obstructive nephropathy

 Variable Etiology of obstruction Degree of obstruction / compliance of collecting

system

Reversibility???????????????

slide-62
SLIDE 62

INDICATIONS FOR PRENATAL INTERVENTION Which Patients Will Benefit?

 Obstructive hydronephrosis

 Progressive

 Bilateral / solitary kidney  Progressive oligohydramnios  Favorable renal function  Minimal / no renal dysplasia  No other severe anatomic / chromosomal

anomalies

slide-63
SLIDE 63

FACTORS PREDICTIVE OF OUTCOME

Amniotic fluid volume Parenchymal echogenicity Degree of hydronephrosis

Least predictive of postnatal renal function Distensibility of collecting system

Renal function Other anomalies

Chromosomes (8-10% abnormal)

slide-64
SLIDE 64

HYDRONEPHROSIS: FACTORS PREDICTIVE OF RENAL OUTCOME

Amniotic fluid volume Parenchymal echogenicity Degree of hydronephrosis Renal function

Urinary chemistries - sequential B-1 microglobulin

Electrolytes Isotonicity

Other anomalies

Chromosomes (8-10% abnormal)

slide-65
SLIDE 65

PROGNOSTIC CRITERIA NORMAL VALUES

Na

<100 mEq/L

Cl

<90 mEq/L

Osm

<210 mOsm/L

Ca

<2 mmol/L

PO4

<2 mmol/L

B2-microglobulin <2 mg/L No cortical cysts

Normal echogenicity

slide-66
SLIDE 66

FETAL URINARY BIOCHEMISTRIES

 Urinary electrolytes may be misleading Obstruction / reversibility Stagnation of urine  Multiple samples improves predictability  Fetal urinary calcium and renal dysplasia

 sensitivity 100%  specificity 60%

 Fetal urinary sodium and renal dysplasia

 sensitivity 87%  specificity 80% Elder, Journal of Urology, 1990 Nicolini, OB GYN, 1993

slide-67
SLIDE 67

ANTENATAL INTERVENTION Unfavorable Prognosis

Early / sustained oligohydramnios < 20 wks  Renal cortical cysts / marked renal

echogenicity

Urinary electrolytes “poor urine”

 Na > 100 m Eq / L  Cl > 90 m Eq / L  Osm > 210 mOsm / L  B-microglobulin > 2 mg / L  Calcium > 8 mg / dl

Reduced lung / thoracic area

slide-68
SLIDE 68

TIMING OF PRENATAL INTERVENTION

< 20 weeks/bilateral hydronephrosis/severe

  • ligohydramnios (??????????)

Irreversible renal dysplasia likely

No intervention

> 32 weeks (? >26 weeks)

Consider early delivery

Assess pulmonary maturity

Normal AF term delivery

slide-69
SLIDE 69

PULMONARY HYPOPLASIA OLIGOHYDRAMNIOS

 Mechanical relationship  Restoration of fluid

 Urinary diversion  Artificial fluid replacement

 Timing critical to prevent pulmonary hypoplasia

slide-70
SLIDE 70

PRENATAL INTERVENTION ETHICAL / LEGAL ISSUES

 Invasive therapy experimental [not evidence-

based]

Knowledge of pulmonary / renal development with

  • r without intervention lacking

Pathophysiology of obstructive uropathy lacking Defined benefits re: outcome not obvious  Conflict of interest First - mother’s health Second - fetus  Must select only fetuses that can benefit from treatment  Most abnormalities best managed postnatally

slide-71
SLIDE 71

PRENATAL INTERVENTION MATERNAL RISK

Operative risk of general anesthesia and

midgestational hysterotomy / intervention

Risk for premature labor following

hysterotomy / intervention

Risk for compromising future reproductive

potential

slide-72
SLIDE 72

PRENATAL INTERVENTION FOR BLADDER OUTLET OBSTRUCTION

 Vesicoamniotic shunt  Complication rate - 50% (<) Shunt migration / poor

drainage

Premature labor Urinary ascites Infection

slide-73
SLIDE 73

OTHER PROCEDURES

Reduce pressure

Vesicocentesis - bladder aspiration –

diagnostic / therapeutic

Multiple sequential

Improve pulmonary development

Restoration amniotic fluid Sequential Multiple amniotic infusions

slide-74
SLIDE 74

OUTCOMES OF SHUNTING

6 studies: 293 patients with

intervention

Oligohydramnios: 44% survival Good urinary prognosis: 85% normal

renal function

Improved survival and renal outcome Poor urinary prognosis: 87.5% postnatal

renal insufficiency

Improved survival / no change renal

  • utcome

Carr Urol Clin NA 2004

slide-75
SLIDE 75

“Just because it can be done, should it be done?” Technology changing indications?

slide-76
SLIDE 76

CONCLUSION: OPTIONS FOR BILATERAL HYDRONEPHROSIS

 1. Observation  Interval monitoring AF, hydronephrosis, renal parenchyma  2. Termination of pregnancy  Appears incompatible with postnatal life Severe renal dysplasia/ pulmonary hypoplasia Appears in less than 20 weeks  3. Early delivery  30-32 weeks Evaluation of lung maturity  4. Intervention  Open fetal surgery/endoscopic surgery  Percutaneous surgery

slide-77
SLIDE 77

Questions

slide-78
SLIDE 78

LOOK TO THE FUTURE

slide-79
SLIDE 79

PARADIGM SHIFT????????

Life-saving therapy

Proved intervention results in viable fetus

Little change in renal function

Life-enhancing therapy

Timely intervention w/o dysplasia /

  • ligohydramnios

EQUALIZER: high complication rate

slide-80
SLIDE 80

Natural History of Prenatal Hydronephrosis

Feldman et al. (J Ultrasound Med, 2001)

20,049 cases: 1.9% with hydro [3rd trimester] 5-8 mm (88%); 9-15 mm (10%); > 15 mm (2%)

100% R

15% R 25% I W 12% U 48% 67% I W 33%

Antenatal US

slide-81
SLIDE 81

Unilateral:

  • UPJ obstruction (39-64%)
  • UVJ obstruction (9-14%)
  • Vesicoureteral reflux (33%)
  • MCDK (4-25%)
  • Ureterocele/ ectopic ureter / Duplex

system

  • PCKD
  • Physiologic
  • Extra-renal pelvis
slide-82
SLIDE 82

OLIGOHYDRAMNIOS

Postnatal Renal Function

slide-83
SLIDE 83

PARENCHYMAL ECHOGENICITY

Postnatal Renal Function

slide-84
SLIDE 84

HYDRONEPHROSIS: FACTORS PREDICTIVE OF OUTCOME

Amniotic fluid volume Parenchymal echogenicity Degree of hydronephrosis Renal function

Urinary chemistries - sequential B-1 microglobulin

Electrolytes Isotonicity

Other anomalies

Chromosomes (8-10% abnormal)

slide-85
SLIDE 85

WHAT CAN WE DETECT IN THE GENITOURINARY TRACT PRENATALLY?

 Hydronephrosis  Absence of kidney(s)  Abnormally developed renal

parenchyma

 Renal cystic disease

 Abnormal bladder development

 Obstructed  Exstrophied  Absence

 Genital anomalies

 Inadequately developed male genitalia  Hydrocele